Fundz

MBX Biosciences Appoints Steven J. Prestrelski, Ph.D.,

PUBLIC · MBXJul 10, 2023

Position

Chief Scientific Officer

Company

MBX Biosciences, Inc.

Steven Prestrelski
sprestrelski@mbxbio.com
CarmelBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharma

Description

CARMEL, Ind., July 10, 2023 -- MBX Biosciences, Inc. , a clinical stage biopharmaceutical company developing Precision Endocrine Peptide™ therapeutics to treat an array of endocrine disorders, today announced the appointment of Steven Prestrelski, Ph.D., M.B.A., as Chief Scientific Officer . Dr

Quick answer

MBX Biosciences Appoints Steven J. Prestrelski, Ph.D., (July 10, 2023). MBX Biosciences, Inc. is based in Carmel, Indiana, United States.

Who is the new Chief Scientific Officer at MBX Biosciences, Inc?
MBX Biosciences, Inc. named Steven Prestrelski Chief Scientific Officer, announced July 10, 2023.
What did MBX Biosciences, Inc. announce on July 10, 2023?
CARMEL, Ind., July 10, 2023 -- MBX Biosciences, Inc. , a clinical stage biopharmaceutical company developing Precision Endocrine Peptide™ therapeutics to treat an array of endocrine disorders, today announced the appointment of Steven Prestrelski, Ph.D., M.B.A., as Chief Scientific Officer .
What does MBX Biosciences, Inc. do?
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company pioneering Precision Endocrine Peptide™ (PEP™) therapeutic candidates to help people with endocrine disorders live fuller and healthier lives.
Where is MBX Biosciences, Inc. based?
MBX Biosciences, Inc. is based in Carmel, Indiana, United States.
Which similar companies made leadership changes around the same time?
Arbutus (July 11, 2023), AbbVie Inc. (June 29, 2023), EyePoint, Inc. (July 10, 2023) and Verastem Oncology (July 11, 2023) also announced leadership changes within 45 days of MBX Biosciences, Inc.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at MBX Biosciences, Inc., and when

A new leader at MBX Biosciences, Inc. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day MBX Biosciences, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MBX Biosciences, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MBX Biosciences, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MBX Biosciences, Inc.

Location

11711 N. Meridian Street, Suite 300

Carmel, Indiana, United States

About

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company pioneering Precision Endocrine Peptide™ (PEP™) therapeutic candidates to help people with endocrine disorders live fuller and healthier lives. The company is advancing a pipeline of PEPs for clinically validated targets designed to deliver superior pharmaceutical properties and overcome key limitations of native peptide therapeutics. MBX’s pipeline includes its lead product candidate MBX 2109, in Phase 2 development for the treatment of hypoparathyroidism (HP), MBX 1416, in Phase 1 development for the treatment of post-bariatric hypoglycemia (PBH) and multiple discovery and pre-clinical candidates in development for the treatment of obesity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MBX Biosciences, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Steven
Likely contact at this company
••••••••@••••••••

See Steven's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for MBX Biosciences, Inc.'s next move

Learn about Strategic plan

MBX Biosciences, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.